Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
Intrinsic Value
Shandong Sanyuan Biotechnology Co Ltd is a CN-based company operating in Food Products industry. [ Read More ]
The intrinsic value of one Shandong Sanyuan Biotechnology Co Ltd stock under the Base Case scenario is 7.36 CNY. Compared to the current market price of 28.32 CNY, Shandong Sanyuan Biotechnology Co Ltd is Overvalued by 74%.
Valuation Backtest
Shandong Sanyuan Biotechnology Co Ltd
Run backtest to discover the historical profit from buying and selling Shandong Sanyuan Biotechnology Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shandong Sanyuan Biotechnology Co Ltd
| Current Assets | 302m |
| Cash & Short-Term Investments | 118m |
| Receivables | 57.7m |
| Other Current Assets | 126.4m |
| Non-Current Assets | 4.5B |
| Long-Term Investments | 58.9m |
| PP&E | 979.1m |
| Intangibles | 47.9m |
| Other Non-Current Assets | 3.4B |
| Current Liabilities | 187.5m |
| Accounts Payable | 40.8m |
| Accrued Liabilities | 6.1m |
| Short-Term Debt | 134.6m |
| Other Current Liabilities | 6m |
| Non-Current Liabilities | 47.3m |
| Other Non-Current Liabilities | 47.3m |
Earnings Waterfall
Shandong Sanyuan Biotechnology Co Ltd
|
Revenue
|
462.7m
CNY
|
|
Cost of Revenue
|
-470.6m
CNY
|
|
Gross Profit
|
-7.9m
CNY
|
|
Operating Expenses
|
-54.7m
CNY
|
|
Operating Income
|
-62.6m
CNY
|
|
Other Expenses
|
116.8m
CNY
|
|
Net Income
|
54.2m
CNY
|
Free Cash Flow Analysis
Shandong Sanyuan Biotechnology Co Ltd
Profitability Score
Profitability Due Diligence
Shandong Sanyuan Biotechnology Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Shandong Sanyuan Biotechnology Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shandong Sanyuan Biotechnology Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Shandong Sanyuan Biotechnology Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shandong Sanyuan Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Sanyuan Biotechnology Co Ltd is 32.64 CNY with a low forecast of 32.32 CNY and a high forecast of 33.6 CNY.
Shareholder Return
Price
Shandong Sanyuan Biotechnology Co Ltd
| Average Annual Return | -53.34% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -74% |
| Market Capitalization | 5.7B CNY |
| Shares Outstanding | 202 326 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shandong Sanyuan Biotechnology Co Ltd is a CN-based company operating in Food Products industry. The company is headquartered in Binzhou, Shandong and currently employs 382 full-time employees. The company went IPO on 2022-02-10. Shandong Sanyuan Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of new sweetener products. The firm's main products are erythritol and compound sugar. The compound sugar products include momordica grosvenori compound sugar, stevia compound sugar, sucralose compound sugar and others. The firm's products are sold to America, Europe, Africa, Oceania and other regions.
Contact
IPO
Employees
Officers
The intrinsic value of one Shandong Sanyuan Biotechnology Co Ltd stock under the Base Case scenario is 7.36 CNY.
Compared to the current market price of 28.32 CNY, Shandong Sanyuan Biotechnology Co Ltd is Overvalued by 74%.
You don't have any saved screeners yet
